| |
| | Mevacor Pharmacology, Pharmacokinetics, Studies, Metabolism - Lovastatin - RxList Monographs |
 | | In the randomized, double-blind, controlled clinical trial, patients were treated with conventional measures (usually diet and 325 mg of aspirin every other day) and either lovastatin 20-80 mg daily or placebo. |
 | | There was no clinically significant change in visual acuity in the patients who had new opacities reported nor was any patient, including those with opacities noted at baseline, discontinued from therapy because of a decrease in visual acuity. |
 | | A three-year, double-blind, placebo-controlled study in hypercholesterolemic patients to assess the effect of lovastatin on the human lens demonstrated that there were no clinically or statistically significant differences between the lovastatin and placebo groups in the incidence, type or progression of lenticular opacities. |
| www.rxlist.com /cgi/generic/lovastat_cp.htm (2549 words) |
|